journal article
Nov 01, 1990
Fluorinated anthracyclines: interactions with DNA
Topics
No keywords indexed for this article. Browse by subject →
References
32
[1]
Arcamone F: Doxorubicin anticancer antibiotics, Academic Press, New York, pp 1–369, 1981
[2]
El Khadem HS: Anthracycline antibiotics, Academic Press, New York, pp 1–282, 1982
[3]
Schwartz HS: Mechanisms of selective cytotoxicity of adriamycin, daunomycin and related anthracyclines. In: Neidle S and Waring MJ (eds), Molecular aspects of anti-cancer drug action. The Macmillan Press Limited, Great Britain, pp 93–125, 1983
10.1007/978-1-349-06010-8_4
[4]
Valentini L, Nicolella V, Vannini E, Menozzi M, Penco S, Arcamone F: Association of anthracycline derivatives with DNA: A fluorescence study. Il Farmaco Ed Sci 40:377–390, 1985
[5]
Fritzsche H, Berg H: Analysis of equilibrium, kinetic and structural data of anthracycline-DNA interaction. Gazz Chim Ital 117:331–352, 1987
[6]
Zbinden G, Bachmann E, Holderegger C: Model systems for cardiac effects of anthracyclines. Antibiot Chemother 23:255–270, 1978
10.1159/000401489
[7]
Brown JR: New natural, semisynthetic and synthetic anthracycline drugs. In: Neidle S and Waring MJ (eds) Molecular aspects of anti-cancer drug action. The Macmillan Press Limited, Great Britain, pp 57–92, 1983
10.1007/978-1-349-06010-8_3
[8]
Tonkin KC, Brownless RTC, Zunino F, Phillips DR: Fluorinated anthracyclines: Synthesis and biological activity. Investig New Drugs 8:1–6, 1990
10.1007/bf00171978
[9]
Bloomfield VA, Crothers DM, Tinoco Jr I: Physical chemistry of nucleic acids. Harper and Row, New York, pp 442–445, 1974
[10]
Wilson WD, Jones RL: Intercalating drugs: DNA binding and molecular pharmacology. Adv Pharmacol Chemother 18: 177–222, 1981
10.1016/s1054-3589(08)60255-0
[11]
Wilson WD, Keel RA, Jones RL, Mosher CW: Viscometric analysis of the interaction of bisphenanthridium compounds with closed circular supercoiled and linear DNA. Nucleic Acids Res 10:4093–4106, 1982
10.1093/nar/10.13.4093
[12]
Neidle S: Interaction of daunomycin and related antibiotics with biological receptors. Topics Antibiotic Chem 2:242–278, 1978
[13]
Gianni L, Corden BJ, Myers CE: The biochemical basis of anthracycline toxicity and antitumour activity. Rev Biochem Toxicol 5:1–82, 1982
[14]
McGhee JD, von Hippel PH: Theoretical aspects of DNA-protein interactions: cooperative and non-cooperative binding of large ligands to a one-dimensional homogenous lattice. J Mol Biol 86:469–489, 1974
10.1016/0022-2836(74)90031-x
[15]
Dougherty G, Pigram WJ: Spectroscopic analysis of drugnucleic acid interactions. CRC Crit Rev Biochem 103–132,1982
10.3109/10409238209108704
[16]
Chaires JB, Dattagupta N and Crothers DM: Studies on interaction of anthracycline antibiotics and DNA: Equilibrium binding studies on interaction of daunomycin with DNA. Biochemistry 21:3933–3940, 1982
10.1021/bi00260a005
[17]
Chaires JB, Dattagupta N, Crothers DM: Kinetics of the daunomycin-DNA interaction. Biochemistry 24:260–267, 1985
10.1021/bi00323a004
[18]
Gandecha B, Brown JR: Dissociation kinetics of DNAanthracycline and DNA-anthraquinone complexes determined by stopped-flow spectrophotometry. Biochem Pharmacol 34:733–736, 1985
10.1016/0006-2952(85)90751-8
[19]
Fox KR, Brasset C, Waring MJ: Kinetics of dissociation of nogalamycin from DNA: comparison with other anthracycline antibiotics. Biochim Biophys Acta 840:383–392, 1985
10.1016/0304-4165(85)90219-3
[20]
Krishnamoorthy CR, Yen S, Smith JC, Lown JW, Wilson WD: Stopped-flow kinetic analysis of the interaction of anthraquinone anticancer drugs with calf thymus DNA, poly[d(G-C)].poly[d(G-C] and poly[d(A-T)].poly[d(A-T)]. Biochemistry 25:5933–5940, 1986
10.1021/bi00368a015
[21]
Phillips DR, Grief PC, Boston RC: Daunomycin-DNA dissociation kinetics. Molec Pharmacol 33:225–230, 1988
[22]
Bolton PH, Mirau PA, Shafer RH, James TL: Interaction of the antimalarial drug fluoroquine with DNA, tRNA and poly(A): 19F-NMR chemical shift and relaxation, optical absorption and fluorescence studies. Biopolymers 20:435–449, 1981
10.1002/bip.1981.360200303
[23]
Feigon J, Denny WA, Leupin W and Kearns DR: The interaction of antitumor drugs with natural DNA: A 1H NMR study of binding mode and kinetics. J Med Chem 27:450–465, 1984
10.1021/jm00370a007
[24]
Chaires JB, Dattagupta and Crothers DM: Self-association of daunomycin. Biochemistry 21:2927–2932, 1982
[25]
Arcamone F: The development of new antitumour anthracyclines. In: Cassady JM and Douros JD (eds), Anticancer agents based on natural product models. Academic Press, New York, pp 1–42, 1980
[26]
Quigley GJ, Wang AH, Ughetto G, der Marel G, van Broom JH, Rich A: Molecular structure of an anti-cancer drug-DNA complex: Daunomycin plus d(CpGpTpApCpG). Proc Natl Acad Sci USA 77:7204–7208, 1980
10.1073/pnas.77.12.7204
[27]
Wang AH, Ughetto, Quigley GJ, Rich A: Interactions between an anthracycline antibiotic and DNA: Molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2 A resolution. Biochemistry 26:1152–1163, 1987
10.1021/bi00378a025
[28]
Holbrook SR, Wang AH, Rich A, Kim S: Local mobility of nucleic acids as determined from crystallographic data. III. A daunomycin-DNA complex. J. Mol Biol 199:349–357, 1988
10.1016/0022-2836(88)90318-x
[29]
Capranico G, Penco S, Tinelli S and Zunino F: Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydaunorubi-cin and 4-demethyl-6-deoxydaunorubicin in murine leukaemia P388 cells. Cancer Res, in press
[30]
Capranico G, Zunino F, Kohn KW and Pommier Y: Se-quence selective topisomerase II inhibition by anthracycline derivatives in SV40 DNA: Relationship with DNA binding affinity and toxicity. Biochemistry, in press.
[31]
Davis AW, Phillips DR: A defined molecular weight distribution of DNA after extensive sonication. Eur J Biochem 173:179–183, 1978
10.1042/bj1730179
[32]
Boston RC, Greif PC, Berman M: Conversational SAAM — an interactive program for kinetic analysis of biological systems. Comput Programs Biomed 13:111–119, 1981
10.1016/0010-468x(81)90089-1
Metrics
3
Citations
32
References
Details
- Published
- Nov 01, 1990
- Vol/Issue
- 8(4)
- Pages
- 355-363
- License
- View
Cite This Article
Ken C. Tonkin, Ray C. Boston, Robert T. C. Brownlee, et al. (1990). Fluorinated anthracyclines: interactions with DNA. Investigational New Drugs, 8(4), 355-363. https://doi.org/10.1007/bf00198591
Related
You May Also Like
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Jonathan E. Rosenberg, Richard M. Bambury · 2013
364 citations
Ipilimumab associated hepatitis: imaging and clinicopathologic findings
Kyung Won Kim, Nikhil H. Ramaiya · 2013
203 citations
Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel™
Ephraim Philip Lansky, Gregory Harrison · 2005
129 citations
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
Michael Millward, Timothy Price · 2011
125 citations
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Eric K. Rowinsky, Agne Paner · 2020
90 citations